AQR Arbitrage’s Travere Therapeutics TVTX Stock Holding History

AQR Arbitrage’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-149,500	Closed	-$3.58M	–	455
2015 Q1	$3.58M	Buy	+149,500	New	+$2.28M	0.05%	195

Other funds holding TVTX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage's TVTX Position: Q2 2015 in Review

AQR Arbitrage sold out of Travere Therapeutics (TVTX) in Q2 2015, closing a stake of 149,500 shares — an estimated $3.58M sold.

AQR Arbitrage first reported a position in TVTX in Q1 2015 and held it in 1 quarter. The position peaked at $3.58M in Q1 2015. 126 funds tracked by Wall St. Rank hold TVTX as of Q2 2015.

AQR Arbitrage reported no remaining Travere Therapeutics position as of Q2 2015 after selling out during the quarter.
AQR Arbitrage sold 149,500 Travere Therapeutics shares in Q2 2015, an estimated $3.58M.
AQR Arbitrage first reported a position in Travere Therapeutics in Q1 2015 and held it in 1 quarter.
AQR Arbitrage's Travere Therapeutics position peaked at $3.58M in Q1 2015.
126 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2015.

Based on AQR Arbitrage's 13F filing for Q2 2015, filed 14 Aug 2015.